Electronic cigarette vapour moderately stimulates pro-inflammatory signalling pathways and interleukin-6 production by human monocyte-derived dendritic cells.
Individual Clinical
Safety
Adverse Effects
Chen (2020)
Electromembrane extraction of nicotine in inhaled aerosols from tobacco cigarettes, electronic cigarettes, and heated tobacco products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Chen (2022)
Increased Levels of the acrolein Metabolite 3-hydroxypropyl Mercapturic acid in the Urine of e-Cigarette Users.
Individual Clinical
Biomarkers
Biommarkers Of Exposure
Chen (2023)
health risks of dual use of electronic and combustible cigarettes: exposure to acrylamide and glycidamide.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
Increased acrolein-DNa adducts in buccal brushings of e-cigarette users.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
association of Vaping and Respiratory health among Youth in the Population assessment of Tobacco and health (PaTh) Study Wave 3.
Individual Clinical
Respiratory Toxicity
Relative Health Effect Of User
Cherian (2021)
Combined associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use habits With Subsequent Short-Term Cardiovascular Disease Risk among South Korean Men: a Nationwide Cohort Study.
Individual Clinical
Safety
Adverse Effects
Choi (2021)
Electronic Cigarettes and alternative Methods of Vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Choi (2021)
Compositional Differences in the Oral Microbiome of E-cigarette Users.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Chopyk (2021)
Biomarkers of Inflammation and Oxidative Stress among adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PaTh Study.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Christensen (2021)